Contract 75N93020P01182
University Of Massachusetts Biologic Labs · Department Of Health And Human Services · August 24, 2020
University Of Massachusetts Biologic Labs was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on August 24, 2020 for an undisclosed amount of work in in-vitro diagnostic substance manufacturing. Performance is in Mattapan, MA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on July 25, 2025.
Contract details
- PIID
- 75N93020P01182
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Mattapan, MA
- First action
- August 24, 2020
- Latest action
- July 25, 2025
Description
DEPLETING RHESUS RECOMBINANTS QTY 44
Modification timeline
-
July 25, 2025Mod P00001$-13.2K
-
August 24, 2020Base award$13.2K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93020P01182?
Contract 75N93020P01182 is a federal contract awarded to University Of Massachusetts Biologic Labs by Department Of Health And Human Services on August 24, 2020 for an undisclosed amount of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75N93020P01182?
University Of Massachusetts Biologic Labs won contract 75N93020P01182 from Department Of Health And Human Services.
How much is contract 75N93020P01182 worth?
Contract 75N93020P01182 has no obligated funds in the available record. It may be a pre-award placeholder or an indefinite-delivery vehicle awaiting task orders.